MINI REVIEW article
Front. Aging Neurosci.
Sec. Parkinson’s Disease and Aging-related Movement Disorders
Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1693827
This article is part of the Research TopicCurrent Status of Diagnosis and Differential Diagnosis of Parkinson's disease and Parkinson's syndromesView all articles
Improving Recognition and Management of Inpatient Delirium in Parkinson's Disease: Evidence Review and Implications for Clinical Care
Provisionally accepted
- 1Parkinson's Foundation Inc, New York, United States
- 2Parkinson’s Disease Foundation, New York, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Delirium is an acute disturbance of attention, arousal, and cognition that fluctuates in severity and is a common yet underrecognized complication in hospitalized patients with Parkinson's disease. In Parkinson's disease, symptoms such as rigidity, bradykinesia, hallucinations, and slowed thinking overlap with the clinical features of delirium, which can obscure its onset in hospitalized patients. Variability in diagnostic criteria further complicates accurate recognition and prevalence estimates. This mini review summarizes current evidence on the prevalence, risk factors, and consequences of delirium in Parkinson's disease (PD) and its associations with mortality and institutionalization. A total of 61 reports published between 1990 and 2025 were included across five domains: delirium diagnosis and prevalence, delirium subtypes, PD-specific delirium rates, risk factors and prevention, and treatment considerations. Foundational evidence reviews and official diagnostic documents (e.g., ICD-10, ICD-11, DSM criteria) were also incorporated as they remain internationally recognized standards for delirium diagnosis. Scholarly studies were appraised using the Joanna Briggs Institute (JBI) Critical Appraisal Checklists, with overall evidence quality judged to be moderate to high, while official diagnostic and guideline documents were considered high-quality based on their authoritative, consensus-driven development. Standardized clinical strategies for hospital management remain limited, but the available evidence supports the use of tailored approaches. We present evidence-based implications for clinical care aligned with the Parkinson's Foundation Hospital Care Standards to improve recognition, prevention, and treatment. We emphasize the need for critical evaluation, methodological consistency, and acknowledgment of the dynamic care challenges posed by delirium in Parkinson's disease.
Keywords: Delirium, Parkinson's disease, PD, diagnosis, Prevalence, Risk factors, prevention, Treatment
Received: 27 Aug 2025; Accepted: 13 Oct 2025.
Copyright: © 2025 Coleman, Smiley, Rosenfield and Brooks. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Anne Brooks, abrooks@parkinson.org
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.